Zuellig Pharma
Concise Prescribing Info
Dorzolamide HCl
Treatment of elevated IOP in patient w/ ocular HTN, open-angle glaucoma, pseudoexfoliative glaucoma & other secondary open-angle glaucoma.
Dosage/Direction for Use
Monotherapy 1 drop tds. Adjunctive therapy w/ an ophth β-blocker 1 drop bd. When substituting for another ophth antiglaucoma agent w/ this product, discontinue the other agent after proper dosing on one day & start Trusopt on the next day. If >1 topical ophth drug is used, the drugs should be administered at least 10 min apart.
Special Precautions
Patients w/ severe renal (CrCl <30 mL/min). Hepatic impairment. Remove soft contact lens prior to administration & do not reinsert <15 min after use. Acute angle glaucoma, sensitivity to sulfonamide. Discontinue if signs of serious reaction/hypersensitivity occurs. Pregnancy & lactation. Childn.
Adverse Reactions
Burning, stinging, conjunctivitis, eyelid inflammation, eye itching, eyelid irritations. Headache, bitter taste, nausea, itching, fatigue/asthenia. Blurred vision, tearing. Rarely, iridocyclitis & rash. Angioedema, bronchospasm, urticaria, pruritus, dizziness, paraesthesia, transient myopia (resolve upon discontinuation) & superficial punctate keratitis have also been reported.
Drug Interactions
High dose of salicylate therapy. Potential additive effect w/ oral carbonic anhydrase inhibitors.
ATC Classification
S01EC03 - dorzolamide ; Belongs to the class of carbonic anhydrase inhibitors. Used in the treatment of glaucoma.
Trusopt eye drops 2 %
5 mL x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in